Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 22, 2026 02:30 ET | Source: Elkedonia

Elkedonia renforce son Comité stratégique avec la nomination de Pierre d'Epenoux comme Président indépendant

Cette nomination renforce la gouvernance d'Elkedonia alors que la société poursuit son développement et prépare ses prochaines étapes de croissancePierre d'Epenoux est l'ancien Président Directeur...
April 22, 2026 02:30 ET | Source: Elkedonia

Elkedonia strengthens Board of Directors with appointment of Pierre d’Epenoux as Independent Chairman

Appointment strengthens Elkedonia's governance as the company continues its development and prepares for its next phases of growthPierre d’Epenoux is former CEO of ImCheck Therapeutics, a...
April 22, 2026 01:00 ET | Source: Axomove

Axomove lève 4 M€ pour accélérer la commercialisation de son dispositif médical numérique de prévention et de rééducation

Axomove lève 4 M€ pour accélérer la commercialisation de son dispositif médical numérique de prévention et de rééducation
April 21, 2026 23:13 ET | Source: Jelenew

Team Elles and Jelenew Partner to Drive Women’s Cycling Community in Loire Atlantique

Team Elles and JELENEW unite in Loire Atlantique to empower women’s cycling, hosting a 200-rider Rando Ride to promote inclusivity and highperformance gear
April 21, 2026 17:00 ET | Source: Aktis Oncology Inc.

Aktis Oncology Announces Presentation of First Clinical Imaging and Dosimetry Data for AKY-2519 at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

AKY-2519, a miniprotein radioconjugate targeting B7-H3, to be featured in two poster presentationsData facilitate initial understanding of AKY-2519 biodistribution and predicted absorbed doses in...
April 21, 2026 16:49 ET | Source: Telix Pharmaceuticals Limited

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

MELBOURNE, Australia and INDIANAPOLIS, April 22, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that safety and tolerability data from the...
April 21, 2026 16:10 ET | Source: Autolus Therapeutics plc

Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Autolus announces inducement grant awards.
April 21, 2026 16:10 ET | Source: CytoDyn Inc.

CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study

Enrollment concludes with just over 60 patients participating across seven clinical sites located throughout the United States VANCOUVER, Washington, April 21, 2026 (GLOBE NEWSWIRE) -- CytoDyn Inc....
April 21, 2026 16:01 ET | Source: Olema Oncology

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting

Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
April 21, 2026 16:00 ET | Source: Belite Bio, Inc

Belite Bio Initiates Rolling Submission of New Drug Application to the U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease

Belite expects to complete the new drug application submission in the second quarter of 2026Rolling submission initiated under Breakthrough Therapy Designation SAN DIEGO, April 21, 2026 (GLOBE...